XML 56 R39.htm IDEA: XBRL DOCUMENT v3.22.1
Net Loss Per Share (Tables)
12 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share
The following table presents the calculation of basic and diluted net loss per share for Class A and Class B common stock. No shares of Class C common stock were issued and outstanding during the periods presented.

Year Ended December 31,
202120202019
Class A
Common
Class B
Common
Class A
Common
Class B
Common
Class A
Common
Class B
Common
(In thousands, except per share data)
Numerator:
Net loss attributable to Blend Labs, Inc.$(151,901)$(18,012)$(50,131)$(24,486)$(48,750)$(32,702)
Less: accretion of RNCI to redemption value(1,323)(107)— — — — 
Net loss attributable to Blend Labs, Inc. common stockholders$(153,224)$(18,119)$(50,131)$(24,486)$(48,750)$(32,702)
Denominator:
Weighted average common stock outstanding, basic and diluted117,994 13,991 26,475 12,932 19,617 13,159 
Net loss per share attributable to Blend Labs, Inc.:
Basic and diluted$(1.30)$(1.30)$(1.89)$(1.89)$(2.49)$(2.49)
Schedule of Antidilutive Securities
The following potential shares of common stock were excluded from the computation of diluted net earnings per share attributable to the Company for the periods presented because including them would have been antidilutive as the Company has reported net loss for each of the periods presented:

As of December 31,
202120202019
(In thousands)
Outstanding stock options31,675 33,750 35,209 
Early exercised options subject to repurchase1,820 162 223 
Options exercised via promissory note— 4,000 4,000 
Non-plan Co-Founder and Head of Blend options26,057 — — 
Unvested restricted stock units2,589 — — 
Common stock warrants598 — 2,807 
Convertible Preferred Stock warrants— 5,461 6,008 
Founders Convertible Preferred Stock— 1,026 1,026 
Convertible Preferred Stock— 121,353 110,898 
   Total antidilutive securities62,739 165,752 160,171